G. A. Simkens

发表

Effective Strategies to Predict Survival of Colorectal Peritoneal Metastases Patients Eligible for Cytoreductive Surgery and HIPEC

I. de Hingh, S. Nienhuijs, G. Simkens, 2021, Cancer management and research.

Systemic therapy in addition to cytoreduction and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: recent insights from clinical studies and translational research.

I. de Hingh, G. Simkens, C. Bakkers, 2020, Journal of gastrointestinal oncology.

Serious Postoperative Complications Affect Early Recurrence After Cytoreductive Surgery and HIPEC for Colorectal Peritoneal Carcinomatosis

G. Nieuwenhuijzen, H. Rutten, M. Luyer, 2015, Annals of Surgical Oncology.

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

A. Zwinderman, J. Tuynman, R. Fehrmann, 2019, BMC Cancer.

Massive surgical emphysema following transanal endoscopic microsurgery.

I. de Hingh, M. Luyer, S. Nienhuijs, 2014, World Journal of Gastrointestinal Surgery.

Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study

H. Rutten, M. Wiezer, B. van Ramshorst, 2016, Journal of surgical oncology.

Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.

V. Lemmens, I. de Hingh, G. Creemers, 2017, European journal of cancer.

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer

I. de Hingh, S. Nienhuijs, G. Simkens, 2017, Cancer management and research.

Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis

G. Nieuwenhuijzen, H. Rutten, M. Luyer, 2016, Annals of Surgical Oncology.

Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery

V. Lemmens, H. Rutten, I. de Hingh, 2016, Medicine.

Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial

A. Aalbers, J. Burger, S. Kruijff, 2023, Annals of Surgical Oncology.

Perioperative systemic therapy for resectable colorectal peritoneal metastases: Sufficient evidence for its widespread use? A critical systematic review.

C. Punt, I. de Hingh, P. Tanis, 2017, Critical reviews in oncology/hematology.

Adjuvant Systemic Chemotherapy vs Active Surveillance Following Up-front Resection of Isolated Synchronous Colorectal Peritoneal Metastases.

C. Punt, V. Lemmens, J. Burger, 2020, JAMA oncology.

Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review

N. Bouvy, P. Dankers, K. Lenaerts, 2022, Clinical & Experimental Metastasis.

Treatment-Related Mortality After Cytoreductive Surgery and HIPEC in Patients with Colorectal Peritoneal Carcinomatosis is Underestimated by Conventional Parameters

M. Luyer, M. Wiezer, S. Nienhuijs, 2015, Annals of Surgical Oncology.

Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases

H. Rutten, I. de Hingh, S. Nienhuijs, 2018, Medicine.

Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parralel-group, phase II-III, randomised, superiority study (CAIRO6)

A. Zwinderman, J. Tuynman, R. Fehrmann, 2019, BMC Cancer.

Comparison of 2 Perioperative Management Protocols and Their Influence on Postoperative Recovery after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Standard Parenteral Nutrition, Selective Bowel Decontamination and Suprapubic Catheters?

A. Bremers, J. D. de Wilt, F. M. K. Elekonawo, 2018, Digestive Surgery.

Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.

C. Punt, V. Lemmens, A. Aalbers, 2017, European Journal of Cancer.

Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC

D. Nieboer, E. Steyerberg, H. Rutten, 2016, Annals of Surgical Oncology.

Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

H. Rutten, G. Creemers, G. Simkens, 2016, Annals of Surgical Oncology.

Primary tumor resection or systemic treatment as palliative treatment for patients with isolated synchronous colorectal cancer peritoneal metastases in a nationwide cohort study

M. Koopman, C. Verhoef, J. D. de Wilt, 2023, Clinical & Experimental Metastasis.

Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.

C. Punt, V. Lemmens, A. Aalbers, 2017, European journal of cancer.